Perspective on cost-effectiveness analysis of chemotherapy for colorectal cancer
Ishiguro, M.; Sugihara, K.; Ishikawa, T.; Uetake, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 589-593
2011
ISSN/ISBN: 0047-1852 PMID: 22214029 Document Number: 655184
Document emailed within 1 workday
Related Documents
Malila, N.; Anttila, A.; Elovainio, L.; Hakulinen, T.; Järvinen, H.; Paimela, H.; Pikkarainen, P.; Rautalahti, M.; Hakama, M. 2003: Screening of colorectal cancer in Finland and analysis of its cost-effectiveness Duodecim; Laaketieteellinen Aikakauskirja 119(12): 1115-1123Palmer, A.J.; Brandt, A. 1996: The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages IIi B and IV non-small cell lung cancer: an Italian perspective Monaldi Archives for Chest Disease 51(4): 279-288
Schrag, D.; Weeks, J. 1999: Costs and cost-effectiveness of colorectal cancer prevention and therapy Seminars in Oncology 26(5): 561-568
Aphinives, P.; Bhudhisawasdi, V.; Sae-seow, O.; Uttaravichien, T. 2006: 5-fluorouracil and mitomycin-C: effective, low-cost chemotherapy for colorectal cancer Journal of the Medical Association of Thailand 89(11): 1885-1889
Biggs, C.G.; Ballantyne, G.H. 1994: Sensitivity versus cost effectiveness in postoperative follow-up for colorectal cancer Current Opinion in General Surgery 1994: 94-102
Fanning, J. 1999: Treatment for early endometrial cancer. Cost-effectiveness analysis Journal of Reproductive Medicine 44(8): 719-723
Yu, D.; Sarol, J.N.; Hutton, G.; Tan, D.; Tanner, M. 2002: Cost-effectiveness analysis of the impacts on infection and morbidity attributable to three chemotherapy schemes against Schistosoma japonicum in hyperendemic areas of the Dongting Lake region, China Southeast Asian Journal of Tropical Medicine and Public Health 33(3): 441-457
Kwon, J.S.; Lu, K.H. 2008: Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women Obstetrics and Gynecology 112(1): 56-63
Tirelli, U.; Berretta, M.; Bearz, A.; Carbone, A. 2011: Grouping of molecularly targeted anti-cancer agents based on cost-effectiveness analysis European Review for Medical and Pharmacological Sciences 15(11): 1355-1356
Lu, G.-c.; Fang, F.; Li, D.-c. 2010: Efficacy and toxicity analysis of XELOX and FOLFOX4 regimens as adjuvant chemotherapy for stage IIi colorectal cancer Zhonghua Zhong Liu Za Zhi 32(2): 152-155
Nerich, V.; Bazan, F.; Compagnat, F.; Dobi, E.; Villanueva, C.; Chaigneau, Lïc.; Perrin, S.; Voidey, A.; Pivot, X.; Limat, S. 2012: First-line bevacizumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimisation analysis Anticancer Research 32(8): 3547-3552
Roungrong, J.; Teerawattananon, Y.; Chaikledkaew, U. 2008: Cost-utility analysis of recombinant human erythropoietin in anemic cancer patients induced by chemotherapy in Thailand Journal of the Medical Association of Thailand 91(Suppl 2): S119-S125
Feng, H.; Song, G.; Yang, J.; Hao, C.; Wang, M.; Li, B.; Zhao, D.; Liu, Z.; Wei, W.; Qiao, Y. 2015: Cost-effectiveness analysis of esophageal cancer once-in-a-lifetime endoscopic screening in high-risk areas of rural China Zhonghua Zhong Liu Za Zhi 37(6): 476-480
Deirdre Wulf 1981: Cost-Benefit and Cost-Effectiveness Analysis for Family Planning Programs International Family Planning Perspectives 7(4): 141-144
Richter, J.M.; Christensen, M.R.; Rustgi, A.K.; Silverstein, M.D. 1989: The clinical utility of the Ca19-9 radioimmunoassay for the diagnosis of pancreatic cancer presenting as pain or weight loss. a cost-effectiveness analysis Archives of Internal Medicine 149(10): 2292-2297
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Wessels, F.; Anderson, A.N.; Kropman, K. 1999: The cost-effectiveness of isotretinoin in the treatment of acne. Part 1. A meta-analysis of effectiveness literature South African Medical Journal 89(7 Pt 2): 780-784
Fuller, J.F. 1974: Cost-benefit and cost-effectiveness analysis New Zealand Dental Journal 70(322): 282-288
Betegón, L.; Cotarelo, M.; Vendrell, Bén. 2012: Cost and cost-effectiveness analysis of the preferred treatment for initial antiretroviral therapy in HIV infected adults according to 2012 GESIDA/National AIDS Plan guidelines Enfermedades infecciosas y microbiologia clinica 30(8): 508-9; author reply 511-2
Tanaka, K.; Kumamoto, T.; Nojiri, K.; Mori, R.; Matsuyama, R.; Takeda, K.; Ota, M.; Akiyama, H.; Ichikawa, Y.; Endo, I. 2010: Prehepatectomy chemotherapy using hepatic artery infusion plus systemic chemotherapy for liver metastases from colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2267-2270